Analysis Tools|
Allele Symbol Allele Name Allele ID |
Rettm2.1Cos targeted mutation 2.1, Frank Costantini MGI:2136896 |
||||||||||||||||||||||||||||
| Summary |
6 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• in most mice, normal secretory cells are replaced with abnormal cells with higher density of nuclei and less volume of basophilic cytoplasm suggestive of pheochromocytoma
|
|
• in most mice, normal secretory cells are replaced with abnormal cells with higher density of nuclei and less volume of basophilic cytoplasm suggestive of pheochromocytoma
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• newborns have bilateral malformations of the adrenal glands
|
|
• mice show incomplete enclosure of the adrenal medulla
|
|
• mice show display nodular chromaffin cell hyperplasia as early as 4 months of age
|
|
• apparent as early as 5 months of age and in every mutant by 6 months of age
|
|
• at 6-10 months of age, 26% display diffuse C-cell hyperplasia and 60% display more advanced nodular C-cell hyperplasia
|
|
• mice show display nodular chromaffin cell hyperplasia as early as 4 months of age
|
|
• develop ganglioneuromas of the adrenal medulla however do not develop ganglioneuromas of the intestinal tract or mucosa
|
|
• consistently display neuromatous enlargement of the sympathetic ganglia along the medial aspect of the adrenal glands and invasion of the sympathetic ganglia into the adrenal gland
|
|
• apparent as early as 5 months of age and in every mutant by 6 months of age
|
|
• develop ganglioneuromas of the adrenal medulla however do not develop ganglioneuromas of the intestinal tract or mucosa
|
|
|
• 83% of males could not impregnate wild-type females although they exhibited normal mounting behavior and had normal gonads and produced mature sperm
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| NOT | familial medullary thyroid carcinoma | DOID:0050547 |
OMIM:155240 |
J:60659 |
| multiple endocrine neoplasia type 2B | DOID:10016 |
OMIM:162300 |
J:60659 | |
| pheochromocytoma | DOID:0050771 |
OMIM:171300 |
J:60659 | |
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• 16-17% display nodular chromaffin cell hyperplasia, rarely progressing to pheochromocytoma
|
|
• 31% of young and 41% of older mutants display diffuse C-cell hyperplasia and 14% have more advanced nodular C-cell hyperplasia
|
|
• 16-17% display nodular chromaffin cell hyperplasia, rarely progressing to pheochromocytoma
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| NOT | familial medullary thyroid carcinoma | DOID:0050547 |
OMIM:155240 |
J:60659 |
| multiple endocrine neoplasia type 2B | DOID:10016 |
OMIM:162300 |
J:60659 | |
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
| N |
• do not exhibit ganglioneuromas, nodular chromaffin cell hyperplasia or pheochromocytomas
|
| N |
• males are fertile
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| NOT | multiple endocrine neoplasia type 2B | DOID:10016 |
OMIM:162300 |
J:60659 |
| NOT | pheochromocytoma | DOID:0050771 |
OMIM:171300 |
J:60659 |
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• mice begin to die around 100 days of age, with 50% survival at 250 days of age
|
|
• mice develop stroma-poor neuroblastoma, with the majority of tumors showing signs of differentiation
|
|
• mice develop stroma-poor neuroblastoma, with the majority of tumors showing signs of differentiation
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| neuroblastoma | DOID:769 | J:261033 | ||
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||


